Drugs Made In America Acquisition II Corp.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Drugs Made In America Acquisition II Corp.'s yearly results, compared with Financial Services companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Not applicable for banks
Deposits and loans are a bank's raw material, so cash-flow and debt figures mean something different for banks.
Self-Funding Ratio
—Not applicable for banks
Deposits and loans are a bank's raw material, so cash-flow and debt figures mean something different for banks.
Cash Locked Ratio
—Not applicable for banks
Deposits and loans are a bank's raw material, so cash-flow and debt figures mean something different for banks.
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
—Not applicable for banks
Deposits and loans are a bank's raw material, so cash-flow and debt figures mean something different for banks.
Cash Cushion Ratio
—Not applicable for banks
Deposits and loans are a bank's raw material, so cash-flow and debt figures mean something different for banks.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (7)
Drugs Made In America Acquisition II Corp. owes $0.04 for every $1 it owns.
Compared with Financial Services companies in United States · latest annual results Dec 2025.
P/E ratio
34.0Investors pay $34.0 for every $1 of Drugs Made In America Acquisition II Corp.'s yearly profit, higher than 90% of Financial Services companies in United States.
P/B ratio
1.31The share price is 1.31 times Drugs Made In America Acquisition II Corp.'s book value per share, higher than 53% of Financial Services companies in United States.
Market cap
$649 MThe total market value of all of Drugs Made In America Acquisition II Corp.'s shares at today's price (share price × number of shares), smaller than 52% of Financial Services companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$496 MWhat Drugs Made In America Acquisition II Corp. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$7.79Net worth divided by the number of shares. The share price of $10.19 is 1.3 times this, which is the P/B above.
Owes vs Owns
0.04×Drugs Made In America Acquisition II Corp. owes $0.04 for every $1 it owns (low), lower than 93% of Financial Services companies in United States. Banks and lenders usually show higher figures.
Dividend yield
NoneDrugs Made In America Acquisition II Corp. does not currently pay a dividend.
Questions
What is Drugs Made In America Acquisition II Corp.'s P/E ratio?
Investors pay $34.0 for every $1 of Drugs Made In America Acquisition II Corp.'s yearly profit, higher than 90% of Financial Services companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Drugs Made In America Acquisition II Corp.: $649 M ÷ $496 M (30 Jun 2026) = 1.3.
How much does Drugs Made In America Acquisition II Corp. owe compared with what it owns?
Drugs Made In America Acquisition II Corp. owes $0.04 for every $1 it owns (low), lower than 93% of Financial Services companies in United States. Banks and lenders usually show higher figures.
Does Drugs Made In America Acquisition II Corp. pay a dividend?
No. Drugs Made In America Acquisition II Corp. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.